Site icon news.soban.in

Emcure slashes obesity drug Poviztra price by up to 55% amid competition(Soban News)

Emcure cuts Poviztra prices by up to 55% following Novo Nordisk’s move, lowering monthly treatment costs for semaglutide-based obesity therapy in India

​Emcure cuts Poviztra prices by up to 55% following Novo Nordisk’s move, lowering monthly treatment costs for semaglutide-based obesity therapy in India by Soban News (international And National News)

Exit mobile version